FDA guidance updates postmarket surveillance program

08/18/2011 | MassDevice.com (Boston)

The FDA has issued guidance outlining the types of devices that may be eligible for postmarket surveillance as well as how manufacturers should comply with the program. The guidance, which will be up for comment over the next three months, also recommends that the 36-month surveillance period be extended for pediatric devices.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN